Skip to main content
. 2023 Nov 6;13(1):97–104. doi: 10.1159/000534937

Table 1.

Baseline clinical characteristics

LVOS (n = 75) Fresh (n = 40) Old (n = 35) p value
Age 69±15 66±17 72±13 0.12
Female gender 41 (55) 22 (55) 19 (54) 1.00
Risk factors
 Hypertension 51 (68) 26 (65) 25 (71) 0.62
 Hyperlipidaemia 22 (29) 11 (28) 11 (31) 0.80
 Current nicotine 14 (19) 7 (18) 7 (20) 1.00
 Diabetes mellitus 11 (15) 8 (20) 3 (9) 0.20
 Family history 12 (16) 6 (15) 6 (17) 1.00
 Atrial fibrillation 30 (40) 16 (40) 14 (40) 1.00
 Vascular disease 30 (40) 15 (38) 15 (43) 0.65
 TIA or stroke in history 14 (19) 7 (18) 7 (20) 1.00
Medication
 Aspirin 16 (21) 8 (20) 8 (23) 0.79
 Clopidogrel 7 (9) 3 (8) 4 (11) 0.70
 OAC/DOAC 21 (28) 10 (25) 11 (31) 0.61
 rTPA 35 (47) 19 (48) 16 (46) 0.88
 NIHSS pre-MT 17 (6.3) 17 (6.0) 18 (6.7) 0.55

Baseline criteria and clinical characteristics of the total study population, and after stratification for thrombus age. Numbers are expressed as frequency (percentage) or mean ± standard deviation.

LVOS, large vessel occlusion stroke; fresh, fresh thrombus (<1 day old); old, old thrombus (>1 day old); TIA, transient ischaemic attack; OAC, oral anticoagulants; DOAC, direct oral anticoagulants; rTPA, recombinant tissue plasminogen activator (thrombolysis); NIHSS, National Institutes of Health Stroke Scale at admission to the hospital; MT, mechanical thrombectomy.